Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:00 PM
Ignite Modification Date:
2025-12-24 @ 2:00 PM
NCT ID:
NCT03182595
Eligibility Criteria:
Inclusion Criteria:
* Healthy males and females, over 18 years of age,
* Informed of the nature of the study and giving written informed consent,
* Report no significant diseases during screening,
* Have normal CBC, renal function and liver enzymology,
* Have no contraindication for paracetamol,
* Be on no regular medical treatment, except for contraceptives,
* Be able to communicate effectively with study personnel.
Exclusion Criteria:
* Hypersensitivity or idiosyncratic reaction to paracetamol,
* Intake of any medication, except for contraceptives, within 14 days before start of the study,
* Pregnancy or breastfeeding,
* BMI \<18 kg/m2,
* Participation in a clinical study of any investigational product 1 month prior to visit 1 or during the study.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03182595
Study Brief:
Protocol Section:
NCT03182595